374
Views
21
CrossRef citations to date
0
Altmetric
Review Articles

Does variation in neurodegenerative disease susceptibility and phenotype reflect cerebral differences at the network level?

&
Pages 487-493 | Received 15 Feb 2013, Accepted 04 Jun 2013, Published online: 24 Jul 2013

References

  • Cajal R. ‘Recollections of my life’. In: CraigieEH, CowanWM, CanoJ, editors. Cambridge MA: MIT Press; 1937.
  • Francis PT. Glutamatergic systems in Alzheimer’s disease. International Journal of Geriatric Psychiatry. 2003;18(Suppl 1):S15–21.
  • Wang X, Michaelis ML, Michaelis EK. Functional genomics of brain aging and Alzheimer’s disease: focus on selective neuronal vulnerability. Current Genomics. 2010;11:618–33.
  • Wang X, Michaelis EK. Selective neuronal vulnerability to oxidative stress in the brain. Frontiers in Aging Neuroscience. 2010;2:12.
  • Bento-Abreu A, van Damme P, van den Bosch L, Robberecht W. The neurobiology of amyotrophic lateral sclerosis. The European Journal of Neuroscience. 2010;31:2247–65.
  • Dewil M, van den Bosch L, Robberecht W. Microglia in amyotrophic lateral sclerosis11. Acta Neurologica Belgica. 2007;107:63–70.
  • Krstic D, Knuesel I. Deciphering the mechanism underlying late-onset Alzheimer’s disease. Nature Reviews Neurology. 2013;9:25–34.
  • Aguzzi A, Barres BA, Bennett ML. Microglia: scapegoat, saboteur, or something else?. Science. 2013;339:156–61.
  • Kiernan MC, Petri S. Hyperexcitability and amyotrophic lateral sclerosis. Neurology. 2012;78:1544–5.
  • Turner MR, Kiernan MC. Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?. Amyotroph Lateral Scler. 2012;13:245–50.
  • Bohnen NI, Albin RL. The cholinergic system and Parkinson’s disease. Behavioural Brain Research. 2011;221:564–73.
  • Gittis AH, Nelson AB, Thwin MT, Palop JJ, Kreitzer AC. Distinct roles of GABAergic interneurons in the regulation of striatal output pathways. The Journal of Neuroscience: the official journal of the Society for Neuroscience. 2010;30: 2223–34.
  • Bowen DM, Procter AW, Mann DM, Snowden JS, Esiri MM, Neary D, et al. Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy. Psychopharmacology (Berl). 2008;196:603–10.
  • Lanctot KL, Herrmann N, Ganjavi H, Black SE, Rusjan PM, Houle S, et al. Serotonin-1A receptors in frontotemporal dementia compared with controls. Psychiatry Res. 2007;156:247–50.
  • Turner MR, Rabiner EA, Hammers A, Al-Chalabi A, Grasby PM, Shaw CE, et al. [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. Brain. 2005;128:896–905.
  • Doder M, Rabiner EA, Turjanski N, Lees AJ, Brooks DJ, Study CWP. Tremor in Parkinson’s disease and serotonergic dysfunction: an 11C-WAY 100635 PET study. Neurology. 2003;60:601–5.
  • Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–3.
  • Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9orf72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–68.
  • DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in non-coding region of C9orf72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245–56.
  • Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurology. 2012;11:323–30.
  • Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9orf72 mutations. Brain. 2012;135:693–708.
  • Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
  • Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, Parkinsonism and other neurological disorders: a review. Brain. 1981;104:217–47.
  • Perl DP, Olanow CW, Calne D. Alzheimer’s disease and Parkinson’s disease: distinct entities or extremes of a spectrum of neurodegeneration?. Annals of Neurology. 1998;44(3 Suppl 1):S19–31.
  • Eisen A, Calne D. Amyotrophic lateral sclerosis, Parkinson’s disease and Alzheimer’s disease: phylogenetic disorders of the human neocortex sharing many characteristics. The Canadian Journal of Neurological Sciences. 1992;19(Suppl): 117–23.
  • Schmidt ML, Lee VM, Saido T, Perl D, Schuck T, Iwatsubo T, et al. Amyloid plaques in Guam amyotrophic lateral sclerosis/Parkinsonism-dementia complex contain species of A beta similar to those found in the amyloid plaques of Alzheimer’s disease and pathological aging. Acta Neuropathologica. 1998;95:117–22.
  • Drachman DA. Do we have brain to spare?Neurology. 2005;64:2004–5.
  • Smit DJ, Boersma M, Schnack HG, Micheloyannis S, Boomsma DI, Hulshoff Pol HE, et al. The brain matures with stronger functional connectivity and decreased randomness of its network. PloS One. 2012;7:e36896.
  • Gervan P, Berencsi A, Kovacs I. Vision first? The development of primary visual cortical networks is more rapid than the development of primary motor networks in humans. PloS One. 2011;6:e25572.
  • Huffman K. The developing, aging neocortex: how genetics and epigenetics influence early developmental patterning and age-related change. Frontiers in Genetics. 2012;3:212.
  • Rakic P, Ayoub AE, Breunig JJ, Dominguez MH. Decision by division: making cortical maps. Trends in Neurosciences. 2009;32:291–301.
  • Rubenstein JL, Anderson S, Shi L, Miyashita-Lin E, Bulfone A, Hevner R. Genetic control of cortical regionalization and connectivity. Cereb Cortex. 1999;9:524–32.
  • Rubenstein JL, Rakic P. Genetic control of cortical development. Cereb Cortex. 1999;9:521–3.
  • Zielinski BA, Gennatas ED, Zhou J, Seeley WW. Network-level structural covariance in the developing brain. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:18191–6.
  • Xu G, Broadbelt KG, Haynes RL, Folkerth RD, Borenstein NS, Belliveau RA, et al. Late development of the GABA-ergic system in the human cerebral cortex and white matter. Journal of Neuropathology and Experimental Neurology. 2011;70:841–58.
  • Cookson MR. Evolution of neurodegeneration. Current Biology: CB. 2012;22:R753–61.
  • Seeley WW, Carlin DA, Allman JM, Macedo MN, Bush C, Miller BL, et al. Early frontotemporal dementia targets neurons unique to apes and humans. Annals of Neurology. 2006;60:660–7.
  • Lang EW, Tome AM, Keck IR, Gorriz-Saez JM, Puntonet CG. Brain connectivity analysis: a short survey. Computational Intelligence and Neuroscience. 2012;2012:412512.
  • van den Heuvel MP, Sporns O. Rich-club organization of the human connectome. J Neurosci. 2011;31:15775–86.
  • Zhou J, Gennatas ED, Kramer JH, Miller BL, Seeley WW. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron. 2012;73:1216–27.
  • Sherwood CC, Subiaul F, Zawidzki TW. A natural history of the human mind: tracing evolutionary changes in brain and cognition. Journal of Anatomy. 2008;212:426–54.
  • Solari SV, Stoner R. Cognitive consilience: primate non-primary neuroanatomical circuits underlying cognition. Frontiers in Neuroanatomy. 2011;5:65.
  • Eisen A. Amyotrophic lateral sclerosis: evolutionary and other perspectives. Muscle Nerve. 2009;40:297–304.
  • Ghika J. Paleoneurology: neurodegenerative diseases are age-related diseases of specific brain regions recently developed by Homo sapiens. Medical Hypotheses. 2008;71:788–801.
  • Knopman DS, Roberts RO. Estimating the number of persons with frontotemporal lobar degeneration in the US population. Journal of Molecular Neuroscience. 2011;45:330–5.
  • Aboitiz F. Gestures, vocalizations, and memory in language origins. Frontiers in Evolutionary Neuroscience. 2012;4:2.
  • Arbib MA, Liebal K, Pika S. Primate vocalization, gesture, and the evolution of human language. Current Anthropology. 2008;49:1053–63; discussion 63−76.
  • Roby-Brami A, Hermsdorfer J, Roy AC, Jacobs S. A neuropsychological perspective on the link between language and praxis in modern humans. Philosophical transactions of the Royal Society of London Series B, Biological sciences. 2012;367:144–60.
  • Budd JM, Kisvarday ZF. Communication and wiring in the cortical connectome. Frontiers in Neuroanatomy. 2012;6:42.
  • Pievani M, de Haan W, Wu T, Seeley WW, Frisoni GB. Functional network disruption in the degenerative dementias. Lancet Neurol. 2011;10:829–43.
  • Smith SM, Fox PT, Miller KL, Glahn DC, Fox PM, Mackay CE, et al. Correspondence of the brain’s functional architecture during activation and rest. Proc Natl Acad Sci U S A. 2009;106:13040–5.
  • Sporns O. The human connectome: a complex network. Ann N Y Acad Sci. 2011;1224:109–25.
  • Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative diseases target large-scale human brain networks. Neuron. 2009;62:42–52.
  • Raj A, Kuceyeski A, Weiner M. A network diffusion model of disease progression in dementia. Neuron. 2012;73:1204–15.
  • Seeley WW. Selective functional, regional, and neuronal vulnerability in frontotemporal dementia. Current Opinion in Neurology. 2008;21:701–7.
  • Perneczky R, Drzezga A, Diehl-Schmid J, Li Y, Kurz A. Gender differences in brain reserve: an (18)F-FDG PET study in Alzheimer’s disease. Journal of Neurology. 2007; 254:1395–400.
  • Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A. 2009;106:7209–14.
  • DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Archives of Neurology. 2007;64:20–4.
  • Niethammer M, Feigin A, Eidelberg D. Functional neuroimaging in Parkinson’s disease. Cold Spring Harbor Perspectives in Medicine. 2012;2:a009274.
  • Kanwisher N. Functional specificity in the human brain: a window into the functional architecture of the mind. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:11163–70.
  • Bak TH, Chandran S. What wires together dies together: verbs, actions and neurodegeneration in motor neuron disease. Cortex. 2012;48:936–44.
  • Braak H, Braak E. Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiology of Aging. 1995;16:271–8; discussion 8−84.
  • Braak H, Ghebremedhin E, Rub U, Bratzke H, del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell and Tissue Research. 2004;318:121–34.
  • Verstraete E, van den Heuvel MP, Veldink JH, Blanken N, Mandl RC, Hulshoff Pol HE, et al. Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study. PLoS One. 2010;5:e13664.
  • Douaud G, Filippini N, Knight S, Talbot K, Turner MR. Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain. 2011;134: 3470–9.
  • Verstraete E, Veldink JH, Mandl RC, van den Berg LH, van den Heuvel MP. Impaired structural motor connectome in amyotrophic lateral sclerosis. PLoS One. 2011;6:e24239.
  • Swash M. How does ALS spread between neurons in the CNS?Journal of Neurology, Neurosurgery, and Psychiatry. 2013;84:116–7.
  • Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M, Riedemann C, Windl O, Steinhoff BJ, et al. The Heidenhain variant of Creutzfeldt-Jakob disease. Archives of Neurology. 1999; 56:55–61.
  • Fling BW, Chapekis M, Reuter-Lorenz PA, Anguera J, Bo J, Langan J, et al. Age differences in callosal contributions to cognitive processes. Neuropsychologia. 2011;49:2564–9.
  • Fling BW, Peltier SJ, Bo J, Welsh RC, Seidler RD. Age differences in interhemispheric interactions: callosal structure, physiological function, and behaviour. Frontiers in Neuroscience. 2011;5:38.
  • Innocenti GM. Dynamic interactions between the cerebral hemispheres. Exp Brain Res. 2009;192:417–23.
  • Ryberg C, Rostrup E, Paulson OB, Barkhof F, Scheltens P, van Straaten EC, et al. Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a three-year follow-up of the LADIS study cohort. Journal of the Neurological Sciences. 2011;307:100–5.
  • Di Paola M, Luders E, Di Iulio F, Cherubini A, Passafiume D, Thompson PM, et al. Callosal atrophy in mild cognitive impairment and Alzheimer’s disease: different effects in different stages. NeuroImage. 2010;49:141–9.
  • Cronin-Golomb A. Parkinson’s disease as a disconnection syndrome. Neuropsychology Review. 2010;20:191–208.
  • Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, Turner MR. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology. 2010;75: 1645–52.
  • Chapman MC, Jelsone-Swain L, Fling BW, Johnson TD, Gruis K, Welsh RC. Corpus callosum area in amyotrophic lateral sclerosis. Amyotroph Lateral Scler: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2012;13:589–91.
  • Wittstock M, Meister S, Walter U, Benecke R, Wolters A. Mirror movements in amyotrophic lateral sclerosis. Amyotroph Lateral Scler: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2011;12:393–7.
  • Paul LK. Developmental malformation of the corpus callosum: a review of typical callosal development and examples of developmental disorders with callosal involvement. Journal of Neurodevelopmental Disorders. 2011;3:3–27.
  • Twine NA, Janitz K, Wilkins MR, Janitz M. Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer’s disease. PLoS One. 2011;6:e16266.
  • Lehmann M, Ghosh PM, Madison C, Laforce R Jr, Corbetta-Rastelli C, Weiner MW, et al. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer’s disease. Brain. 2013;136: 844–58.
  • Rakic P. Evolution of the neocortex: a perspective from developmental biology. Nature Reviews Neuroscience. 2009;10:724–35.
  • Turner M, Goldacre R, Goldacre M. Reduced cancer incidence in Huntington’s disease: record linkage study clue to an evolutionary trade-off?Clinical Genetics. 2013;83:588–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.